A sTudy of Low Dose vs Standard Dose of tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Diabetes Mellitus Patients

NCT04307511 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome Patients With Diabetes After PCI

Interventions

DRUG: Ticagrelor
DRUG: Aspirin

Sponsor

Shanghai Tong Ren Hospital